fda warning letters compounded semaglutide september 2025 COMES FOR NOVO DRAMA. #medicine #wellness #news #life #hospital US FDA sends 25 letters

When you are eating, GLP-1 sends the brain the Im full signal

The current thinking is that in many people with obesity, that signal exists but isn't getting through loudly enough, a kind of appetite dysregulation

Ozempic and its counterparts have recently gained rapid popularity given its ability to suppress appetite, resulting in rapid weight loss for many users

Your eligibility for Semaglutide depends on several factors, including Type 2 diabetes or obesity, overall health status, and specific criteria outlined by your healthcare professionals

Content on social media is often unverified, leaving people to sort through the information they come across on their feeds to determine what is real and what may be misleading or incorrect

We keep a close eye on nutrition and hydration to make sure your progress stays healthy and sustainable